RANI
Rani Therapeutics Holdings, Inc.$0.86-0.03 (-3.20%)Prev Close$0.89·MCap$58.1M·P/E—·Vol315.7K·Yield—
▲
Buys (12M)
1
$1.26M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$1.26M
●
Active Insiders
1
last 12 mo
Over the past 12 months, insider activity at Rani Therapeutics Holdings, Inc. (RANI) has been exclusively buying, with 1 insider purchase totaling $1.26M and 0 insider sales totaling $0.00. The most recent insider transaction was by IMRAN MIR A (Director), who purchased $1.26M worth of shares on Oct 23, 2025. Rani Therapeutics Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $58.1M.
RANI Insider Trading Activity
Showing 1–50 of 56
1 / 2
RANI Insider Buying Activity
The following table shows recent insider purchases of Rani Therapeutics Holdings, Inc. (RANI) stock reported via SEC Form 4 filings.
RANI Insider Selling Activity
The following table shows recent insider sales of Rani Therapeutics Holdings, Inc. (RANI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 17, 2024 | South Cone Investments Limited Partnership | 10% Owner | Sell | 3,829,360 | $2.65 | $10.14M5.9% OS | 8,825,932-30% |
| Dec 8, 2023 | Quiroga Cortes Isidoro Alfonso | 10% Owner | Sell | 5,265,165 | $2.01 | $10.58M8.1% OS | 8,400-100% |
RANI Insiders
South Cone Investments Limited Partnership
10% Owner
Bought $12.78MSold $10.14M
40 tradesLast: Oct 17, 2024
Similar Stocks to RANI
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B